Multicenter phase II study of whole-body and intracranial activity with ceritinib in patients with ALK-rearranged non-small-cell lung cancer previously treated with chemotherapy and crizotinib: Results from ASCEND-2
SCAGLIOTTI, Giorgio Vittorio;
2016-01-01
File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients WithALK-Rearranged Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib_ Results From ASCEND-2.pdf
Accesso aperto
Tipo di file:
PDF EDITORIALE
Dimensione
968.12 kB
Formato
Adobe PDF
|
968.12 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.